Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Imagem de Miniatura
Arquivos
art_MAO_Integrative_oncology_Addressing_the_global_challenges_of_cancer_2022.PDF (505.94 KB)
Citações na Scopus
150
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
MAO, Jun J.
PILLAI, Geetha Gopalakrishna
ANDRADE, Carlos Jose
LIGIBEL, Jennifer A.
BASU, Partha
COHEN, Lorenzo
KHAN, Ikhlas A.
MUSTIAN, Karen M.
PUTHIYEDATH, Rammanohar
DHIMAN, Kartar Singh
Citação
CA-A CANCER JOURNAL FOR CLINICIANS, v.72, n.2, p.144-164, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The increase in cancer incidence and mortality is challenging current cancer care delivery globally, disproportionally affecting low- and middle-income countries (LMICs) when it comes to receiving evidence-based cancer prevention, treatment, and palliative and survivorship care. Patients in LMICs often rely on traditional, complementary, and integrative medicine (TCIM) that is more familiar, less costly, and widely available. However, spheres of influence and tensions between conventional medicine and TCIM can further disrupt efforts in evidence-based cancer care. Integrative oncology provides a framework to research and integrate safe, effective TCIM alongside conventional cancer treatment and can help bridge health care gaps in delivering evidence-informed, patient-centered care. This growing field uses lifestyle modifications, mind and body therapies (eg, acupuncture, massage, meditation, and yoga), and natural products to improve symptom management and quality of life among patients with cancer. On the basis of this review of the global challenges of cancer control and the current status of integrative oncology, the authors recommend: 1) educating and integrating TCIM providers into the cancer control workforce to promote risk reduction and culturally salient healthy life styles; 2) developing and testing TCIM interventions to address cancer symptoms or treatment-related adverse effects (eg, pain, insomnia, fatigue); and 3) disseminating and implementing evidence-based TCIM interventions as part of comprehensive palliative and survivorship care so patients from all cultures can live with or beyond cancer with respect, dignity, and vitality. With conventional medicine and TCIM united under a cohesive framework, integrative oncology may provide citizens of the world with access to safe, effective, evidence-informed, and culturally sensitive cancer care.
Palavras-chave
cancer prevention, complementary, alternative, and integrative medicine, global health, health policy, survivorship
URI
https://observatorio.fm.usp.br/handle/OPI/48826
Referências
  1. Afungchwi GM, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1719-y
  2. Aggarwal BB, 2006, EXPERT OPIN THER TAR, V10, P87, DOI 10.1517/14728222.10.1.87
  3. Aisner D L, NCCN CLIN PRACTICE G
  4. Aliyu UM, 2017, NIGER J CLIN PRACT, V20, P1576, DOI 10.4103/njcp.njcp_88_17
  5. American Association for Cancer Research(AACR), AACR CANC PROGR REP
  6. American Association for the Advancement of Science, 2014, SCIENCE, V346, P1564
  7. Andersen SR, 2013, ACTA ONCOL, V52, P336, DOI 10.3109/0284186X.2012.745948
  8. Anderson JG, 2012, J ALTERN COMPLEM MED, V18, P235, DOI 10.1089/acm.2011.0022
  9. Armenian S, NCCN CLIN PRACTICE G
  10. Armer JS, 2020, JNCI CANCER SPECT, V4, DOI 10.1093/jncics/pkz098
  11. Asiimwe JB, 2021, EVID-BASED COMPL ALT, V2021, DOI 10.1155/2021/9963038
  12. Sitarek P, 2020, CANCERS, V12, DOI 10.3390/cancers12102957
  13. Smith MC, 2003, ALTERN THER HEALTH M, V9, P40
  14. Soden K, 2004, PALLIATIVE MED, V18, P87, DOI 10.1191/0269216304pm874oa
  15. Soerjomataram I, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-125
  16. Stubbe Dorothy E, 2018, Focus (Am Psychiatr Publ), V16, P60, DOI 10.1176/appi.focus.20170052
  17. Sun LY, 2021, INTEGR CANCER THER, V20, DOI 10.1177/15347354211020105
  18. Sun LY, 2017, J GLOB ONCOL, V3, P692, DOI 10.1200/JGO.2016.007955
  19. Sun LY, 2018, INTEGR CANCER THER, V17, P885, DOI 10.1177/1534735418777117
  20. Sundararajan R, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-033410
  21. Bower JE, 2021, J CLIN ONCOL, V39, P3473, DOI 10.1200/JCO.21.00279
  22. Kumar S, 2013, CURR OPIN SUPPORT PA, V7, P216, DOI 10.1097/SPC.0b013e3283610255
  23. Sung HH, 2022, CLIN EXP HYPERTENS, V44, P146, DOI 10.1080/10641963.2021.2007943
  24. Tarver T, 2012, J CONS HLTH INTERNET, V16, P366, DOI 10.1080/15398285.2012.701177
  25. Tauchen J, 2019, NAT PROD RES, V33, P2718, DOI 10.1080/14786419.2018.1462180
  26. Thomson CA, 2016, CONTEMP CLIN TRIALS, V49, P181, DOI 10.1016/j.cct.2016.07.005
  27. Tian GH, 2021, J EVID-BASED MED, V14, P65, DOI 10.1111/jebm.12420
  28. Tiloke C, 2018, BIOMED PHARMACOTHER, V108, P457, DOI 10.1016/j.biopha.2018.09.060
  29. Toth M, 2013, J ALTERN COMPLEM MED, V19, P650, DOI 10.1089/acm.2012.0466
  30. Tovey P, 2006, INTEGR CANCER THER, V5, P232, DOI 10.1177/1534735406291493
  31. TRIMBLE E, 2017, J NATL CANCER INST M, V2017
  32. Trondle M, 2021, COMPLEMENT THER MED, V58, DOI 10.1016/j.ctim.2021.102681
  33. Kutner JS, 2008, ANN INTERN MED, V149, P369, DOI 10.7326/0003-4819-149-6-200809160-00003
  34. Boyd C, 2016, PAIN MED, V17, P1553, DOI 10.1093/pm/pnw100
  35. United Nations, RES AD GEN ASS 25 SE
  36. Velicer CM, 2008, J CLIN ONCOL, V26, P665, DOI 10.1200/JCO.2007.13.5905
  37. Viscuse PV, 2017, CURR OPIN ONCOL, V29, P235, DOI 10.1097/CCO.0000000000000376
  38. Vyas Purvi, 2010, Ayu, V31, P417, DOI 10.4103/0974-8520.82029
  39. Walker EM, 2010, J CLIN ONCOL, V28, P634, DOI 10.1200/JCO.2009.23.5150
  40. Wang LM, 2017, JAMA-J AM MED ASSOC, V317, P2515, DOI 10.1001/jama.2017.7596
  41. Ward ZJ, 2021, LANCET ONCOL, V22, P1301, DOI 10.1016/S1470-2045(21)00403-4
  42. Weeks J, 2020, J ALTERN COMPLEM MED, V26, P82, DOI 10.1089/acm.2020.29082.jjw
  43. WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1
  44. Labidi S, 2020, B CANCER, V107, P209, DOI 10.1016/j.bulcan.2019.10.007
  45. WHO, 2014, 67 WORLD HLTH ASS 20
  46. Brahmi Sami Aziz, 2011, Pan Afr Med J, V10, P36
  47. Wild C. E., 2020, WORLD CANC REP CANC
  48. Williams AF, 2002, EUR J CANCER CARE, V11, P254, DOI 10.1046/j.1365-2354.2002.00312.x
  49. Witt Claudia M., 2017, Journal of the National Cancer Institute Monographs, P3, DOI 10.1093/jncimonographs/lgx012
  50. World Cancer Research Fund/American Institute for Cancer Research, 2018, DIET NUTR PHYS ACT O
  51. World Health Organization, 2013, WHO TRADITIONAL MED, P76
  52. World Health Organization, 2002, PROGR TRAD MED WHO T
  53. World Health Organization (WHO), WHO REP PROGR FIGHT
  54. World Health Organization WHO, 2015, AGEING HLTH
  55. Lacomba MT, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5396
  56. Wu M, 2015, ONCOTARGET, V6, P38283, DOI 10.18632/oncotarget.5711
  57. Wurtzen H, 2013, EUR J CANCER, V49, P1365, DOI 10.1016/j.ejca.2012.10.030
  58. Brazilian Academic Consortium for Integrative Health, BRAZ AC CONS INT HLT
  59. Xiang Y, 2018, J PAIN RES, V11, P83, DOI 10.2147/JPR.S152743
  60. Xu YC, 2020, J PAIN SYMPTOM MANAG, V59, P966, DOI 10.1016/j.jpainsymman.2019.10.018
  61. Xu Yun, 2017, Journal of the National Cancer Institute Monographs, P19, DOI 10.1093/jncimonographs/lgx015
  62. Yang MX, 2021, BIOMED PHARMACOTHER, V140, DOI 10.1016/j.biopha.2021.111727
  63. Yang MX, 2021, PHYTOMEDICINE, V82, DOI 10.1016/j.phymed.2021.153459
  64. Yeh HC, 2020, OBESITY, V28, P1678, DOI 10.1002/oby.22936
  65. Yeung KS, 2018, ONCOLOGY-NY, V32, P516
  66. Ladas EJ, 2014, PEDIATR BLOOD CANCER, V61, P687, DOI 10.1002/pbc.24791
  67. Yun Hyeongjun, 2017, Journal of the National Cancer Institute Monographs, P29, DOI 10.1093/jncimonographs/lgx004
  68. Zainal NZ, 2013, PSYCHO-ONCOLOGY, V22, P1457, DOI 10.1002/pon.3171
  69. Zeng YC, 2018, INTEGR CANCER THER, V17, P737, DOI 10.1177/1534735418777109
  70. Brenner DR, 2019, PREV MED, V122, P49, DOI 10.1016/j.ypmed.2019.03.014
  71. Zetzl T, 2021, SUPPORT CARE CANCER, V29, P2973, DOI 10.1007/s00520-020-05794-2
  72. Zhang YB, 2020, BRIT J CANCER, V122, P1085, DOI 10.1038/s41416-020-0741-x
  73. Broom Alex, 2009, Oman Med J, V24, P99, DOI 10.5001/omj.2009.24
  74. Brown KF, 2018, BRIT J CANCER, V118, P1130, DOI 10.1038/s41416-018-0029-6
  75. Bruni L, 2021, PREV MED, V144, DOI 10.1016/j.ypmed.2020.106399
  76. BVS MTCI Americas, JORN INT MED INT HOS
  77. Latorre Palma Claudia G., 2016, Journal of Dietary Supplements, V13, P221, DOI 10.3109/19390211.2015.1008612
  78. Guido PC, 2015, EUR J INTEGR MED, V7, P5, DOI 10.1016/j.eujim.2014.06.010
  79. Carlson LE, 2004, PSYCHONEUROENDOCRINO, V29, P448, DOI 10.1016/S0306-4530(03)00054-4
  80. Carlson LE, 2013, J CLIN ONCOL, V31, P3119, DOI 10.1200/JCO.2012.47.5210
  81. Cassileth BR, 2004, J PAIN SYMPTOM MANAG, V28, P244, DOI 10.1016/j.jpainsymman.2003.12.016
  82. Chen G, 2015, J HUAZHONG U SCI-MED, V35, P808, DOI 10.1007/s11596-015-1511-5
  83. Chen Z, 2008, J ALTERN COMPLEM MED, V14, P1049, DOI 10.1089/acm.2008.0039
  84. *CHIN MED COUNC HO, DEV CHIN MED HONG KO
  85. China's State Council Information Office, 2016 WHIT PAP TRAD
  86. Choedon T, 2010, J ETHNOPHARMACOL, V129, P208, DOI 10.1016/j.jep.2010.03.011
  87. Chwistek, NCCN CLIN PRACTICE G
  88. Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602
  89. Clairet AL, 2019, MED ONCOL, V36, DOI 10.1007/s12032-019-1267-z
  90. Communication Strategy Research Office Center for International Communication Studies, 2015, 2015 CHINA NATL IMAG
  91. Courneya KS, 2008, CURR ONCOL, V15, P262
  92. D'Alessandro E, 2013, ACUPUNCT MED, V31, P23, DOI 10.1136/acupmed-2012-010206
  93. Dans M., NCCN CLIN PRACTICE G
  94. Campos MPD, 2011, J ALTERN COMPLEM MED, V17, P505, DOI 10.1089/acm.2010.0571
  95. De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546
  96. Defo BK, 2014, GLOBAL HEALTH ACTION, V7, P17, DOI 10.3402/gha.v7.22443
  97. del Giglio Adriana Braz, 2013, Journal of Dietary Supplements, V10, P325, DOI 10.3109/19390211.2013.830676
  98. Department of Primary Care Office of Health Care Ministry of Health of Brazil, 2008, NATL POL INT COMPL P
  99. Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200
  100. Desai AG, 2008, CURR DRUG METAB, V9, P581, DOI 10.2174/138920008785821657
  101. Deshmukh V, 2014, SUPPORT CARE CANCER, V22, P3007, DOI 10.1007/s00520-014-2294-0
  102. Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE
  103. Donoyama N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196638
  104. Ezzo J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003475.pub2
  105. Ferlay J., 2020, GLOBAL CANC OBSERVAT
  106. Fernandez T, 2003, J ETHNOPHARMACOL, V85, P81, DOI 10.1016/S0378-8741(02)00361-6
  107. Ferraz Ivana Santos, 2020, Enfermería Actual de Costa Rica, P196, DOI 10.15517/revenf.v0i38.37750
  108. Fundacion Arturo Lopez Perez, TER COMPL
  109. Fundacion para Combatir la Leucemia (FUNDALEU), MED INT
  110. Lee BL, 2012, LANCET ONCOL, V13, pE95, DOI 10.1016/S1470-2045(11)70323-0
  111. Gallagher EJ, 2013, DIABETES CARE, V36, pS233, DOI 10.2337/dcS13-2001
  112. Gallagher EJ, 2015, PHYSIOL REV, V95, P727, DOI 10.1152/physrev.00030.2014
  113. Gallego-Perez DF, 2020, REV PANAM SALUD PUBL, V44, DOI 10.26633/RPSP.2020.143
  114. Gallicchio L, 2021, JNCI-J NATL CANCER I, V113, P1136, DOI 10.1093/jnci/djab049
  115. Garland SN, 2021, J CANCER SURVIV, V15, P951, DOI 10.1007/s11764-021-01001-1
  116. Garland SN, 2017, J NATL CANCER INST M, V2017
  117. Geerse OP, 2018, CANCER-AM CANCER SOC, V124, P4435, DOI 10.1002/cncr.31723
  118. Gelband H, 2016, LANCET, V387, P2133, DOI 10.1016/S0140-6736(15)00755-2
  119. Gerson-Cwilich Raquel, 2006, Clin Transl Oncol, V8, P200
  120. Gilchrist SC, 2020, JAMA ONCOL, V6, P1210, DOI 10.1001/jamaoncol.2020.2045
  121. Lengacher CA, 2016, J CLIN ONCOL, V34, P2827, DOI 10.1200/JCO.2015.65.7874
  122. Giordano A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102376
  123. Giovannucci E, 2010, J CLIN ONCOL, V28, P4081, DOI 10.1200/JCO.2009.27.3219
  124. Girdhani S, 2005, J Cancer Res Ther, V1, P129
  125. Gomez-Martinez R, 2007, PEDIATR BLOOD CANCER, V49, P820, DOI 10.1002/pbc.21101
  126. Gopal S, 2021, JAMA-J AM MED ASSOC, V326, P809, DOI 10.1001/jama.2021.12778
  127. Grant SJ, 2019, INTEGR CANCER THER, V18, DOI 10.1177/1534735418823266
  128. Greenlee H, 2017, CA-CANCER J CLIN, V67, P195, DOI 10.3322/caac.21397
  129. Greenlee Heather, 2014, Journal of the National Cancer Institute Monographs, P346, DOI 10.1093/jncimonographs/lgu041
  130. He W, 2013, J TRADIT CHIN MED, V33, P403, DOI 10.1016/S0254-6272(13)60187-9
  131. He YH, 2020, JAMA ONCOL, V6, P271, DOI 10.1001/jamaoncol.2019.5233
  132. Asiki G, 2016, ACTA PAEDIATR, V105, P191, DOI 10.1111/apa.13252
  133. Henderson V, 2012, BREAST CANCER RES TR, V131, P99, DOI 10.1007/s10549-011-1738-1
  134. Hershman DL, 2018, JAMA-J AM MED ASSOC, V320, P167, DOI 10.1001/jama.2018.8907
  135. Holmboe-Ottesen G, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.18891
  136. Horneber M, 2012, INTEGR CANCER THER, V11, P187, DOI 10.1177/1534735411423920
  137. Hospital Israelita Albert Einstein, SUPPL THER
  138. Hou YN, 2019, CANCER J, V25, P357, DOI 10.1097/PPO.0000000000000403
  139. Hsu WC, 2015, DIABETES CARE, V38, P150, DOI 10.2337/dc14-2391
  140. Hu CQ, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/1720239
  141. International Atomic Energy Agency, DIR RAD CTR DIRAC
  142. International Narcotics Control Board (INCB), NARC DRUGS TECHN REP
  143. Lesi G, 2016, J CLIN ONCOL, V34, P1795, DOI 10.1200/JCO.2015.63.2893
  144. Islami F, 2018, CA-CANCER J CLIN, V68, P31, DOI 10.3322/caac.21440
  145. Jeon J, 2018, ANN INTERN MED, V169, P684, DOI [10.7326/M18-1250, 10.7326/m18-1250]
  146. Jia Libin, 2017, Journal of the National Cancer Institute Monographs, P58, DOI 10.1093/jncimonographs/lgx007
  147. Jiang H, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0713
  148. Joint United Nations Programme on HIV/AIDS (UNAIDS), 2006, COLL TRAD HEAL HIV P
  149. Key T, 2004, PUBLIC HEALTH NUTR, V7, P187, DOI 10.1079/PHN2003588
  150. Kiecolt-Glaser JK, 2014, J CLIN ONCOL, V32, P1040, DOI 10.1200/JCO.2013.51.8860
  151. Kinkead B, 2018, CANCER-AM CANCER SOC, V124, P546, DOI 10.1002/cncr.31064
  152. Knaul FM, 2011, CLOSING CANC DIVIDE
  153. Krohn M, 2011, SUPPORT CARE CANCER, V19, P1303, DOI 10.1007/s00520-010-0946-2
  154. Li JX, 2011, CURR ONCOL REP, V13, P290, DOI 10.1007/s11912-011-0169-9
  155. Kumar DRN, 2015, PAK J PHARM SCI, V28, P83
  156. Kumar D, 2016, SOUTH ASIAN J CANCER, V5, P8, DOI 10.4103/2278-330X.179689
  157. Ligibel JA, 2017, NPJ BREAST CANCER, V3, DOI 10.1038/s41523-017-0040-8
  158. Ligibel JA, 2014, J CLIN ONCOL, V32, P3568, DOI 10.1200/JCO.2014.58.4680
  159. Lim EJ, 2017, J ALTERN COMPLEM MED, V23, P8, DOI 10.1089/acm.2016.0263
  160. Lin PJ, 2018, CURR ONCOL REP, V20, DOI 10.1007/s11912-018-0657-2
  161. Linos E, 2008, JNCI-J NATL CANCER I, V100, P1352, DOI 10.1093/jnci/djn305
  162. Listing M, 2009, PSYCHO-ONCOLOGY, V18, P1290, DOI 10.1002/pon.1508
  163. Liu J, 2021, ANN PALLIAT MED, V10, P1895, DOI 10.21037/apm-20-865
  164. Liu J, 2020, INTEGR CANCER THER, V19, DOI 10.1177/1534735420944491
  165. Ataguba JEO, 2012, HEALTH ECON POLICY L, V7, P309, DOI 10.1017/S1744133110000356
  166. Liu J, 2019, CANCER J, V25, P367, DOI 10.1097/PPO.0000000000000404
  167. Livingston Julie, 2012, IMPROVISING MED AFRI
  168. LoConte NK, 2018, J CLIN ONCOL, V36, P83, DOI 10.1200/JCO.2017.76.1155
  169. de Paula LCL, 2015, J ALTERN COMPLEM MED, V21, P22, DOI 10.1089/acm.2014.0127
  170. Lopes Gilberto, 2019, J Glob Oncol, V5, P1, DOI 10.1200/JGO.18.00213
  171. Lopez G, 2019, CANCER J, V25, P311, DOI 10.1097/PPO.0000000000000401
  172. Lopez-Gil S, 2017, DRUG METAB REV, V49, P338, DOI 10.1080/03602532.2017.1335750
  173. Ly A, 2016, CANC THER ONCOL INT, V2
  174. Ly A., 2018, J TUMOR MED PREV, V3
  175. Lyman GH, 2018, J CLIN ONCOL, V36, P2647, DOI 10.1200/JCO.2018.79.2721
  176. Bae JY, 2020, PLANTA MED, V86, P144, DOI 10.1055/a-1037-4051
  177. Malvicini M, 2018, MOL CANCER THER, V17, P966, DOI 10.1158/1535-7163.MCT-17-0193
  178. MAO JJ, 2017, J NATL CANCER INST M, V2017
  179. Mao JJ, 2021, JAMA ONCOL, V7, P720, DOI 10.1001/jamaoncol.2021.0310
  180. Mao JJ, 2017, J ONCOL PRACT, V13, pE207, DOI 10.1200/JOP.2016.015081
  181. Mao JJ, 2015, J CLIN ONCOL, V33, P3615, DOI 10.1200/JCO.2015.60.9412
  182. Mao JJ, 2011, J CANCER SURVIV, V5, P8, DOI 10.1007/s11764-010-0153-7
  183. Martinez R, 2020, LANCET GLOB HEALTH, V8, pE511, DOI 10.1016/S2214-109X(20)30035-8
  184. Mathur P, 2020, JCO GLOB ONCOL, V6, P1063, DOI 10.1200/GO.20.00122
  185. Mclntyre, 2007, LEARNING EXPERIENCE
  186. McQuade JL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/504507
  187. Bao T, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.0681
  188. Boccolini PDM, 2020, BMC COMPLEMENT MED, V20, DOI 10.1186/s12906-020-2842-8
  189. Ministerio da Saude, PRAT INT E COMPL PIC
  190. Moadel AB, 2007, J CLIN ONCOL, V25, P4387, DOI 10.1200/JCO.2006.06.6027
  191. Mohammed OOP, 2020, INT J SCI ADV, V1, P49
  192. Molassiotis A, 2019, INTEGR CANCER THER, V18, DOI 10.1177/1534735419836501
  193. Molina AI, 2005, MEDICINA-BUENOS AIRE, V65, P390
  194. Mooney K., NCCN CLIN PRACTICE G, DOI [10.1200/jco.2016.71.8478, DOI 10.1200/JCO.2016.71.8478]
  195. Moral-Munoz JA, 2019, INTEGR CANCER THER, V18, DOI 10.1177/1534735419846401
  196. Mustian KM, 2016, SEMIN ONCOL NURS, V32, P383, DOI 10.1016/j.soncn.2016.09.002
  197. Mustian Karen M, 2012, Oncol Hematol Rev, V8, P81
  198. Barni MV, 2012, ONCOL REP, V27, P1041, DOI 10.3892/or.2012.1630
  199. Mustian KM, 2013, J CLIN ONCOL, V31, P3233, DOI 10.1200/JCO.2012.43.7707
  200. Nahleh Z, 2008, CURR ONCOL, V15, P271
  201. Namisango E., APCA ATLAS PALLIATIV
  202. Nascimento FS, 2015, HEMATOL ONCOL, V33, P280
  203. National Comprehensive Cancer Network (NCCN), NCCN GUID SUPP CAR
  204. Nekhlyudov L, 2019, JNCI-J NATL CANCER I, V111, P1120, DOI 10.1093/jnci/djz089
  205. Ng SSM, 2013, GASTROENTEROLOGY, V144, P307, DOI 10.1053/j.gastro.2012.10.050
  206. Noto Y, 2010, J ANESTH, V24, P827, DOI 10.1007/s00540-010-1028-9
  207. O'Hara GA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005842
  208. Office of Cancer Complementary and Alternative Medicine National Cancer Institute, 2016, INT ACT
  209. Ben-Arye E, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0511-1
  210. Paice JA, 2016, J CLIN ONCOL, V34, P3325, DOI 10.1200/JCO.2016.68.5206
  211. Palliyaguru DL, 2016, MOL NUTR FOOD RES, V60, P1342, DOI 10.1002/mnfr.201500756
  212. Qazi AK, 2018, CARCINOGENESIS, V39, P522, DOI 10.1093/carcin/bgy024
  213. Rack B, 2010, BREAST CARE, V5, P395, DOI 10.1159/000322677
  214. Raghavendra RM, 2009, INTEGR CANCER THER, V8, P37, DOI 10.1177/1534735409331456
  215. Raimi IO, 2020, J HERB MED, V23, DOI 10.1016/j.hermed.2020.100371
  216. Rao MR, 2009, COMPLEMENT THER MED, V17, P1, DOI 10.1016/j.ctim.2008.05.005
  217. Reitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-X
  218. Riba MB, NCCN CLIN PRACTICE G
  219. Rocha V, 2017, J GLOB ONCOL, V3, P701, DOI 10.1200/JGO.2016.006809
  220. Bhoo-Pathy N, 2017, EUR J CANCER, V74, P26, DOI 10.1016/j.ejca.2016.12.014
  221. Rojas TR, 2018, INTEGR CANCER THER, V17, P52, DOI 10.1177/1534735416681642
  222. Rosenbaum E, 2004, SUPPORT CARE CANCER, V12, P293, DOI 10.1007/s00520-004-0599-0
  223. Rtveladze K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068785
  224. Ruiz GG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159857
  225. Samano Eliana Sueco Tibana, 2004, Sao Paulo Med. J., V122, P60, DOI 10.1590/S1516-31802004000200005
  226. Sánchez Ricardo, 2015, Rev. salud pública, V17, P699, DOI 10.15446/rsap.v17n5.38695
  227. Araujo MDS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/676984
  228. Secretaria de Atencao Primaria a Saude Ministerio da Saude Brasil, POL NACL PRAT INT CO
  229. Shah SC, 2019, J GLOB ONCOL, V5, DOI 10.1200/JGO.18.00200
  230. Shetty N, 2019, INDIAN J MED PAEDIAT, V40, P365, DOI 10.4103/ijmpo.ijmpo_200_17
  231. Bower Julienne E, 2005, Cancer Control, V12, P165
  232. Shipkowski KA, 2018, FOOD CHEM TOXICOL, V118, P963, DOI 10.1016/j.fct.2018.04.007

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICr
Artigos e Materiais de Revistas Científicas - LIM/26
Artigos e Materiais de Revistas Científicas - ODS/03